Skip to main content
Premium Trial:

Request an Annual Quote

Investment Bank Cuts ABI Stock Rating, Though Says Firm Can Meet Revenue Targets

NEW YORK, Dec. 2 (GenomeWeb News) - Investment bank Lehman Brothers today cut Applied Biosystems' stock rating to "equal-weight" from "overweight."

 

Though it said it continues to believe the company can meet revenue and earnings targets, the recent increase in the share price no longer warrants an overweight rating, Lehman Brothers said.

 

The broker said the recent run-up in the share price may be related to the company's stock buyback program.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more